Compare PIPR & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PIPR | BRKR |
|---|---|---|
| Founded | 1895 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.5B |
| IPO Year | 2003 | 2000 |
| Metric | PIPR | BRKR |
|---|---|---|
| Price | $299.06 | $39.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $362.50 | $49.54 |
| AVG Volume (30 Days) | 195.5K | ★ 2.3M |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.56% | 0.50% |
| EPS Growth | ★ 54.49 | N/A |
| EPS | ★ 15.82 | N/A |
| Revenue | ★ $1,904,217,000.00 | $1,895,600,000.00 |
| Revenue This Year | $13.09 | $5.75 |
| Revenue Next Year | $14.76 | $3.99 |
| P/E Ratio | $19.20 | ★ N/A |
| Revenue Growth | ★ 24.33 | N/A |
| 52 Week Low | $202.91 | $28.53 |
| 52 Week High | $380.26 | $56.22 |
| Indicator | PIPR | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 36.74 | 40.57 |
| Support Level | $248.90 | $35.70 |
| Resistance Level | $347.70 | $42.89 |
| Average True Range (ATR) | 14.28 | 1.80 |
| MACD | -2.62 | 0.33 |
| Stochastic Oscillator | 16.16 | 54.69 |
Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.